Picture of Asymchem Laboratories Tianjin Co logo

6821 Asymchem Laboratories Tianjin Co Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapContrarian

Momentum

Relative Strength (%)
1m-12.45%
3m-22.73%
6m-53.06%
1yr-42.25%
Volume Change (%)
10d/3m-38.54%
Price vs... (%)
52w High-53.28%
50d MA-12.14%
200d MA-35.04%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.74
PEG Ratio (f)n/a
EPS Growth (f)-18.87%
Dividend Yield (f)1.69%
Valuation (ttm)IndustryMarket
Price to Book Value1.13
Price to Tang. Book1.17
Price to Free Cashflow8.52
Price to Sales2.51
EV to EBITDA3.96

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital14.24%
Return on Equity13.7%
Operating Margin32.7%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueCNYm2,459.993,149.694,638.8310,255.337,825.196,883.088,667.9333.65%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+29.21+28.69+42.26+187.52-30.98-33.68+32.23n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Asymchem Laboratories Tianjin Co EPS forecast chart

Profile Summary

Asymchem Laboratories (Tian Jin) Co Ltd is a China-based company mainly engaged in the contract development manufacturing organization (CDMO) of drugs. The Company's main businesses are the process development, amplification and commercialization of chemical drugs. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company is also engaged in the provision of pharmaceutical formulation solutions, biosynthetic solutions and clinical solutions.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    October 7th, 1998
    Public Since
    November 18th, 2016
    No. of Shareholders
    56,460
    No. of Employees
    9,788
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    hk flag iconStock Exchange of Hong Kong Limited
    Shares in Issue
    369,471,533

    6821 Share Price Performance

    Similar to 6821

    Picture of 3D Medicines logo

    3D Medicines

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of 3SBio logo

    3SBio

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of AIM Vaccine Co logo

    AIM Vaccine Co

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Ascletis Pharma logo

    Ascletis Pharma

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Guangzhou Baiyunshan Pharmaceutical Holdings Co logo

    Guangzhou Baiyunshan Pharmaceutical Holdings Co

    hk flag iconStock Exchange of Hong Kong Limited

    FAQ